Clinical trial
A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus
NCT00361101 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00361101 |
|---|---|
| Title | A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus |
| Official title | Multicenter, Dose-finding Safety and Activity Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus. |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections, X4 Tropic Virus |
| Intervention type | Drug |
| Interventions | AMD11070 |
| Enrollment | 10 |
| Start date | Oct 1, 2005 |
| Primary completion | Aug 1, 2006 |
| Completion | Apr 1, 2010 |
| First posted | Aug 7, 2006 |
| Last update posted | Feb 11, 2014 |
| Countries | United Kingdom, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: